Immunocore Holdings Plc Adr (IMCR)

Finanzdaten der Immunocore Holdings Plc Adr-Aktie (IMCR)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	8.67%115.93	106.68	104.48	103.69	97.96
Cost Of Revenue	150.69%1.09	0.43	2.70	0.51	1.04
	15.96%43.89	37.85	-	-	-
Selling, General, and Administrative	15.96%43.89	37.85	-	-	-
Research and Development	21.00%73.95	61.11	-	-	-
Operating Income/Loss	141.15%-3.00	7.28	-19.69	-7.17	-14.88
Income/Loss From Continuing Operations Before Tax	103.87%-0.51	13.27	-15.79	0.30	-9.69
Income Tax Expense/Benefit	2.33%0.29	0.30	14.27	0.48	0.61
	106.23%-0.81	12.97	-30.06	-0.18	-10.30
Attributable To Parent	106.23%-0.81	12.97	-30.06	-0.18	-10.30
Basic Average Shares	0.43%50.97	50.75	0.08	50.40	50.29
Diluted Average Shares	3.70%50.97	52.93	0.08	50.40	50.29
Basic Earnings Per Share	107.69%-0.02	0.26	-0.60	-	-0.20
Diluted Earnings Per Share	108.00%-0.02	0.25	-0.60	-	-0.20